hero image
Michael Fendrich, Ph.D. - University of Connecticut. Hartford, CT, US

Michael Fendrich, Ph.D. Michael Fendrich, Ph.D.

Associate Dean for Research and Professor of Social Work | University of Connecticut

Hartford, CT, UNITED STATES

Michael Fendrich is an expert on policies, services, interventions, and risk factors related to substance misuse and mental health.

Biography

Michael Fendrich, Ph.D. is a Professor and the Associate Dean for Research at the School of Social Work. His research focuses on policies, services, interventions, and risk factors related to substance misuse and mental health. He has received considerable extramural funding support from public and private sources. Michael’s most recent work addresses the current opioid crisis and mental health services for youth. Michael is a quantitative researcher who employs survey research methods. He teaches research courses in the doctoral program.

Areas of Expertise (3)

Risk Factors for Substance Misuse

Research Design

Addiction and Mental Health Services

Education (3)

Columbia University: M.S. 1987

University of Texas - Austin: Ph.D. 1985

Haverford College: B.A., Sociology and Anthropology 1978

Media

Publications:

Documents:

Photos:

loading image

Videos:

Audio:

Articles (5)

Impact of Mobile Crisis Services on Emergency Department Use Among Youths With Behavioral Health Service Needs Psychiatric Services

2019

Youths are using emergency departments (EDs) for behavioral health services in record numbers, even though EDs are suboptimal settings for service delivery. In this article, the authors evaluated a mobile crisis service intervention implemented in Connecticut with the aim of examining whether the intervention was associated with reduced behavioral health ED use among those in need of services.

view more

Implementing access to medication assisted treatment in a drug treatment court: Correlates, consequences, and obstacles Journal of Offender Rehabilitation

2019

We sought to understand the implementation of medication-assisted treatment (MAT) access for opioid-involved participants in an urban Midwestern drug treatment court (DTC) over a time period beginning in October 2012 and ending in June 2016. Among those whose primary substance problem on the Addiction Severity Index (ASI) was identified as heroin or other opioids, less than half accessed MAT while they participated in the DTC.

view more

Factors Related to Medication Self-Management in African American Older Women Research in Gerontological Nursing

2019

Individuals with multiple chronic diseases are often prescribed medications for each condition and thus must manage a drug regimen. Medication self-management is challenging for most individuals with chronic diseases, but it can be especially difficult for African American older women. This study investigated how medical mistrust, caregiver role strain, and other relevant variables may be associated with medication self-management behaviors (MSMB) among African American older women, and whether goal congruence and self-efficacy mediated the relationship between the predictor variables and MSMB. A sample of 116 African American older (age> 50 years) women from central Milwaukee participated in this correlational, cross-sectional study.

view more

Prescription Drug Monitoring Programs and pharmacist orientation toward dispensing controlled substances Substance Use & Misuse

2018

We sought to understand how pharmacists viewed and used a newly implemented prescription drug monitoring program (PDMP). We also sought to understand pharmacist orientation toward dispensing of controlled substances and the people who obtain them. Methods: We conducted three mini focus groups.

view more

Ethyl glucuronide in hair and fingernails as a long‐term alcohol biomarker Addiction

2013

Alcohol biomarkers are an objective measure of alcohol exposure or alcohol use that can augment self‐report and clinical history 1, 2. Older alcohol biomarkers involve indirect detection through such markers as gamma‐glutamyltransferase and carbohydrate‐deficient transferrin, which can be elevated as the result of large amounts of ingested alcohol or due to a number of alcohol‐independent (i.e. unrelated) medical conditions.

view more